GlaxoSmithKline Plc
(NYSE : GSK)

( )
GSK After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 3.32%133.080.7%$2112.60m
PFEPfizer Inc. 3.53%32.870.9%$1387.47m
MRKMerck & Co., Inc. 4.12%76.840.7%$1300.89m
ABBVAbbVie, Inc. 2.37%75.162.3%$1236.30m
BMYBristol-Myers Squibb Co. 1.47%55.171.0%$1077.97m
LLYEli Lilly & Co. 4.20%142.151.1%$915.90m
NVSNovartis AG 3.25%83.560.2%$310.08m
AZNAstraZeneca Plc -0.11%43.731.2%$290.86m
GSKGlaxoSmithKline Plc 1.34%37.720.2%$255.80m
FTSVForty Seven, Inc. -0.01%95.430.0%$186.11m
NVONovo Nordisk A/S -0.74%59.310.1%$171.16m
SNYSanofi 1.40%43.510.2%$159.05m
BHCBausch Health Cos., Inc. -1.31%13.570.0%$88.68m
RARXRa Pharmaceuticals, Inc. -0.03%48.000.8%$82.28m
RGENRepligen Corp. 2.78%96.957.1%$73.08m

Company Profile

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The CET segment refers to the management of business activities. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.